Metrosouth Urology

Urologic Expertise and Care For You

Prostate Cancer ADT May Reduce Autoimmune Disease Risk

January 31, 2019 Share this content: Androgen deprivation therapy recipients had a significantly lower risk for autoimmune diseases overall and for Graves’ disease, uveitis, and psoriasis. Androgen deprivation therapy (ADT) for prostate cancer (PCa) may reduce the risk of developing autoimmune dis...
Read More

Prostate Cancer Death Risk Linked to Post-EBRT Time to PSA Nadir

January 29, 2019 Share this content: Men with unfavorable-risk prostate cancer who had a detectable PSA nadir and a time to PSA nadir less than 12 months had a 5-fold increased risk of dying from their disease. Men with a short time to PSA nadir (TTN) and a detectable PSA nadir following external be...
Read More

Prostate Cancer AS Can Be Safe for Men Younger Than 60

January 28, 2019 Share this content: Five-year survival outcomes of prostate cancer active surveillance are similar for men younger than 60 and those aged 60 and older, study finds. Active surveillance (AS) is a viable option for select men younger than 60 years who have low-volume, low-risk prostat...
Read More

Fusion Biopsies in Prostate Cancer AS Predict Progression Risk

January 25, 2019 Share this content: Negative findings on a confirmatory fusion biopsy are associated with a lower risk of Grade Group progression. Men on active surveillance (AS) for prostate cancer who have negative results from a confirmatory fusion biopsy (FB) are at significantly lower risk for...
Read More

PCa Phenotype May Predict Response to Immune Checkpoint Blockade

January 18, 2019 Share this content: The MSI-H/dMMR phenotype is uncommon among men with advanced prostate cancer, but its presence is associated with greater likelihood of a durable response to PD-1/PD-L1 inhibitors. Immune checkpoint blockade may benefit men with advanced prostate cancer (PCa) who...
Read More

Younger Men With High-Grade PCa Less Likely to Die After RP Than RT

January 14, 2019 Share this content: Patients younger than age 60 with Gleason 8–10 disease who had upfront surgery versus radiation therapy had a 63% lower risk of prostate cancer-specific mortality. Men younger than 60 years with localized high-grade prostate cancer are less likely to die from t...
Read More

Early Post-RP Complications Directly Related to Age

January 11, 2019 Share this content: The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer. Virtually all early postoperative radical prostatectomy (RP) complications are directly related to patient ag...
Read More

New Surrogate Marker for ADT Evaluation Proposed

Copyright © 2018 Haymarket Media, Inc. All Rights ReservedThis material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions....
Read More

Overactive Bladder Linked to Prostate Cancer ADT

January 07, 2019 Share this content: Compared with men receiving androgen deprivation therapy for prostate cancer, healthy men had a 98% decreased risk of overactive bladder, study finds. Androgen deprivation therapy (ADT) for prostate cancer is associated with an increased risk of overactive bladde...
Read More